Business Okta outlines 9% revenue growth target for FY 2027 as AI agent security drives new product momentum
Business TriplePoint Venture Growth outlines $25M–$50M quarterly fundings target amid AI portfolio shift in 2026
Business Magnachip outlines 2026 product launches with new generation products to comprise 10% of revenue
Business Alto Ingredients outlines $15M 45Z tax credit target for 2026 amid expanded CO2 operations and cost reductions
Business Niagen Bioscience targets 10–15% revenue growth for 2026 while expanding injectable product line
Business Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy
Business Smith Micro outlines leadership transition and targets Q2 2026 non-GAAP profitability amid strong SafePath OS momentum